see pubmed.org ristori +bcg
The head of the numc needs an education
Our Phase II Trial Has Launched Read the press release
Interested in the Phase II Trial?
Please email us directly.
------------
Your donation will directly support our Phase II research.
Raised to date: $20 million
Our total need: $25.2 million.
Raised to date: $20 million
Our total need: $25.2 million.
The Faustman Lab at Massachusetts General Hospital
Denise Faustman, MD, PhD, is Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH) and an Associate Professor of Medicine at Harvard Medical School. Her current research focuses on discovering and developing new treatments for type 1 diabetes and other autoimmune diseases, including Crohn's disease, lupus, scleroderma, rheumatoid arthritis, Sjögren's syndrome, and multiple sclerosis. She is currently leading a human clinical trial program testing the efficacy of the BCG vaccine for reversal of long-term type 1 diabetes. Positive results from the Phase I study were reported in 2012.Dr. Faustman's type 1 diabetes research has earned her notable awards such as the Oprah Achievement Award for “Top Health Breakthrough by a Female Scientist” (2005), the "Women in Science Award" from the American Medical Women’s Association and Wyeth Pharmaceutical Company for her contributions to autoimmune disease research (2006), and the Goldman Philanthropic Partnerships/Partnership for Cures “George and Judith Goldman Angel Award” for research to find an effective treatment for type 1 diabetes (2011). Her previous research accomplishments include the first scientific description of modifying donor tissue antigens to change their foreignness. This achievement earned her the prestigious National Institutes of Health and National Library of Medicine “Changing the Face of Medicine” Award (2003) as one of 300 American physicians (one of 35 in research) honored for seminal scientific achievements in the United States.
Dr. Faustman earned her MD and PhD from Washington University School of Medicine in St. Louis, Missouri, and completed her internship, residency, and fellowships in Internal Medicine and Endocrinology at the Massachusetts General Hospital in Boston, Massachusetts.
Victor Politi was appointed president of Nassau Health Care Corp. by the board in January 2014. Photo Credit: NuHealth / NUMC / Steven Lev
The public benefit corporation that runs Nassau University Medical Center has agreed to a multiyear extension of its contract with president and chief executive Victor Politi, although the board declined to release a copy of the contract, its terms or a description of the new deal.
The only terms made public were read into the record before the Nassau Health Care Corp. board voted last Thursday night to renew Politi’s contract from July 31 through Dec. 31, 2019, for an annual salary of $368,387, according to a video of the meeting.
Politi, a former acting Nassau County police commissioner and former deputy county executive who also is a physician, was appointed president of NHCC by the board in January 2014 and was approved by County Executive Edward Mangano. Mangano, a Republican, is not running for re-election this fall as he fights federal corruption charges.
Peter Clines, Nassau’s Democratic legislative counsel, said the deal includes an automatic two-year extension for Politi if the board does not take action to terminate the contract. A hospital spokeswoman said she did not have a copy of the contract but said the new deal includes a one-year extension.
Politi will be paid severance if terminated, but the amount was not disclosed.
Board member Warren Zysman abstained on the vote, alleging that newly appointed board member Bobby Kumar Kalotee had threatened him about the contract. Zysman asked that security escort him to his car “for my safety.”
ADVERTISEMENT | ADVERTISE ON NEWSDAY
But Kalotee, a native of India and a former Nassau Independence Party chairman, denied any threats and said Zysman may have misunderstood his accent. “I threatened nobody at all,” Kalotee said later.
Zysman could not be reached for comment.
Clines at the meeting asked for a copy of the contract, but was told there was no contract, according to the video of the meeting taken by Gaspare Tumminello, a Democratic aide who accompanied Clines.
Clines asked for its terms and was told there was no listing of them. He asked for a copy of the description provided to board members when they met behind closed doors to discuss the deal, but was told there was no written description.
Hospital spokeswoman Shelley Lotenberg did not address most questions about the contract or the alleged threat.
She said in a statement Friday, “The NHCC board of directors voted last night to approve the renewal for Dr. Politi’s contract through Dec. 31, 2019, based on his outstanding accomplishments over the last three and half years. It is the role and responsibility of the Board to address these matters based upon the corporation’s enabling legislation.” She said that Politi’s pay is below other hospital presidents in the area.
Lotenberg said in an interview the board has sole authority over executive pay and Mangano’s approval is not needed. “We’re not a county hospital,” she said. “We’re a public benefit corporation. It does not get county taxpayer funds.”
Nassau sold the hospital to the public benefit corporation in 1999 but is liable for more than $242 million in long-term debt if NHCC defaults.
The 15-member NHCC board is controlled by appointees of the political party in power at the county, currently Republicans.
Clines had asked that the contract discussion occur in public and that the board investigate the “threats and intimidation” alleged by Zysman.
ADVERTISEMENT | ADVERTISE ON NEWSDAY
But board counsel John Ciampoli said the contract was “a personnel matter. It should be decided in executive session.” Ciampoli also declined an investigation, saying, “It is my sincere hope that my friends will get along with my friends.”
Kalotee said Friday that Zysman misunderstood comments he made at a previous meeting. Kalotee said he received last-minute notification of that meeting, his first since he was reappointed to the board.
“I said on the record if they are doing something that is not legal, why did they not inform me about the meeting? Why didn’t they inform Newsday? Why didn’t they inform everybody? If they do not, that is a crime and I will call the proper authority to legally investigate.”
He said, “I didn’t threaten anybody individually. I said we must abide by the rules and regulations of the board.”
|
No comments:
Post a Comment